Faith-based approaches may be effective in reaching vaccine-hesitant communities, a new survey found. Forty-four percent of vaccine-hesitant Americans said religious leaders or informational sessions held at their places of worship could sway their attitudes about vaccination. (TIME)
New data released by Bristol Myers Squibb on its psoriasis drug deucravacitinib showed it was more effective at treating the disease than placebo. The pill was also shown to be safe and less toxic than JAK inhibitors. (STAT)
A new study by Novavax and Oxford’s Jenner Institute revealed that their experimental malaria vaccine was 77% effective. If the vaccine proves effective in a Phase III trial, it could represent a breakthrough in fighting the disease. (Endpoints News)
The European Commission is planning to pursue legal action against AstraZeneca over its under-delivery of COVID-19 vaccine doses. Some E.U. countries, however, argued against a lawsuit, saying it might further reduce the public’s confidence in the vaccine. (POLITICO)
More than 30 colleges are now requiring COVID-19 vaccines for fall 2021. They include Yale, Georgetown and Wesleyan. (CNBC Weekly)
